Common Contracts
4 similar License Agreement contracts by Clearmind Medicine Inc., Cannapowder, Inc., Therapix Biosciences Ltd.
LICENSE AGREEMENTLicense Agreement • January 22nd, 2025 • Clearmind Medicine Inc. • Pharmaceutical preparations
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD., of Hi Tech Park, Edmond J. Safra Campus, Givat Ram, Jerusalem 91390, Israel (“Yissum”) of the first part; and CLEARMIND MEDICINE INC., a company organized under the laws of the Province of British Columbia, Canada, on behalf of itself and its Affiliates (the “Company”), of the second part;
LICENSE AGREEMENTLicense Agreement • January 22nd, 2025 • Clearmind Medicine Inc. • Pharmaceutical preparations
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD., of Hi Tech Park, Edmond J. Safra Campus, Givat Ram, Jerusalem 91390, Israel (“Yissum”) of the first part; and CLEARMIND MEDICINE INC., a company organized under the laws of the Province of British Columbia, Canada, on behalf of itself and its Affiliates (the “Company”), of the second part;
LICENSE AGREEMENTLicense Agreement • May 25th, 2018 • Cannapowder, Inc. • Pharmaceutical preparations
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD., of Hi Tech Park, Edmond J. Safra Campus, Givat Ram, Jerusalem 91390, Israel (“Yissum”), of the first part; and CANNA POWDER LTD, of 20 Raul Wallenberg, Tel Aviv, Israel (the “Company”), of the second part; (each of Yissum and the Company, a “Party”, and collectively the “Parties”)
Confidential portions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission (the “Commission”)** LICENSE AGREEMENTLicense Agreement • May 1st, 2017 • Therapix Biosciences Ltd. • Pharmaceutical preparations
This Research and License Agreement (“Agreement”) is made in Jerusalem this 30th day of March 2017 (the “Effective Date”), by and between: